SKYWALK-FOG

Developer: GYENNO

Category: Tools

Add App to Comparison

42 installs

Ratings not yet available

2.00 monthly active users

Revenue not available

SKYWALK-FOG Summary

SKYWALK-FOG is a mobile Android app in Tools by GYENNO. Released in Jun 2022 (3 years ago). It has about 42+ installs Based on AppGoblin estimates, it reaches roughly 2.00 monthly active users . Store metadata: updated May 28, 2025.

Store info: Last updated on Google Play on May 28, 2025 .

SDKs, Trackers & Permissions

App not yet scanned for SDKs.

App Details

Store ID: com.gyenno.fog2

First Released: 2022-06-22

Store Last Updated: 2025-05-28

In-App Purchases: No

Ads: No

Website: gyenno.com

App Store

Crawl Status: Success

AppGoblin First Crawled: 2023-10-22

AppGoblin Last Crawled: 2026-03-16

Ads & App-Ads.txt

App does not have ads.

AppGoblin SDK Scans

App not yet analyzed for SDKs.

The download and scan process is automated but can require manual troubleshooting. Feel free to reach out if your request does not complete in 24hrs or if you have any questions.

0★

Ratings: 0

5★

4★

3★

2★

1★

Screenshots

App Description

SKYWALK APP is the management platform for your SKYWALK device

GYENNO SCIENCE is committed to advancing medical development with emerging technologies and providing personalized medical services for Parkinson's patients.

GYENNO SCIENCE's self-developed auxiliary intelligent device - "SKYWALK BOLD", can collect gait characteristic signals through the built-in sensor module, and use the artificial intelligence-based FOG automatic recognition algorithm to identify abnormal gait in real time, and Automatically turn on the laser or rhythm assistance to help Parkinson's patients effectively release the freezing state, thereby improving the quality of life of Parkinson's patients.

* Disclaimer
The relevant information content and data in the app are for objective reference only and do not serve as a basis for diagnosis. Outside of using this app, professional medical advice should be sought before making any medical decisions.
* Scope of application
This product is only available in EU member states, UK and US.